1518 GMT - The health system in the U.K. needs to develop a more attractive investment environment, AstraZeneca's chief executive officer Pascal Soriot says in a media call. High taxes and access issues have created problems for the entire industry, he says. The British pharma giant last week withdrew plans to invest in a vaccine plant in Liverpool after what it called a cut in government support. Shares are up 5.8% at 117.70 pounds. (helena.smolak@wsj.com)
(END) Dow Jones Newswires
February 06, 2025 10:18 ET (15:18 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.